Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Northland Capital Markets Downgrades Edwards Lifesciences (EW) to Market Perform
April 25, 2018 8:12 AM EDTNorthland Capital Markets downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Market Perform with a price target of $120.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $134.67 yesterday.
... MoreEdwards Lifesciences (EW) PT Lowered to $145 at Evercore ISI
April 25, 2018 6:40 AM EDTEvercore ISI lowered its price target on Edwards Lifesciences (NYSE: EW) to $145.00 (from $151.00) while maintaining an Outperform rating following results.
... More